| sphingolipid metabolic process | GO:0006665 | 45 | 0.943 | |
| lysosome organization | GO:0007040 | 21 | 0.868 | |
| lytic vacuole organization | GO:0080171 | 21 | 0.735 | |
| vacuole organization | GO:0007033 | 38 | 0.650 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.486 | |
| glycosphingolipid catabolic process | GO:0046479 | 5 | 0.466 | |
| ceramide metabolic process | GO:0006672 | 31 | 0.403 | |
| membrane lipid biosynthetic process | GO:0046467 | 32 | 0.376 | |
| sphingoid metabolic process | GO:0046519 | 5 | 0.273 | |
| ceramide biosynthetic process | GO:0046513 | 20 | 0.266 | |
| cation homeostasis | GO:0055080 | 212 | 0.257 | |
| maintenance of location | GO:0051235 | 89 | 0.251 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.217 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.216 | |
| sphingolipid catabolic process | GO:0030149 | 7 | 0.215 | |
| glycolipid metabolic process | GO:0006664 | 25 | 0.206 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.189 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.189 | |
| glycosylceramide metabolic process | GO:0006677 | 4 | 0.176 | |
| liposaccharide metabolic process | GO:1903509 | 27 | 0.145 | |
| regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling | GO:0003027 | 1 | 0.143 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.143 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.140 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.138 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.126 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.119 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.118 | |
| mechanoreceptor differentiation | GO:0042490 | 67 | 0.116 | |
| protein localization to cell leading edge | GO:1902463 | 1 | 0.115 | |
| regulation of protein localization | GO:0032880 | 231 | 0.104 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.102 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.102 | |
| nuclear membrane organization | GO:0071763 | 4 | 0.096 | |
| negative regulation of vesicle fusion | GO:0031339 | 1 | 0.096 | |
| glycolipid catabolic process | GO:0019377 | 5 | 0.092 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.091 | |
| organelle assembly | GO:0070925 | 177 | 0.089 | |
| locomotory behavior | GO:0007626 | 195 | 0.089 | |
| endocytosis | GO:0006897 | 168 | 0.087 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.084 | |
| actin filament branching | GO:0090135 | 1 | 0.081 | |
| protein processing | GO:0016485 | 163 | 0.073 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.073 | |
| cellular response to nerve growth factor stimulus | GO:1990090 | 3 | 0.072 | |
| cellular homeostasis | GO:0019725 | 240 | 0.070 | |
| regulation of calcium ion transport into cytosol | GO:0010522 | 31 | 0.070 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.070 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.066 | |
| regulation of vascular smooth muscle contraction | GO:0003056 | 1 | 0.066 | |
| positive regulation of leukocyte mediated cytotoxicity | GO:0001912 | 31 | 0.063 | |
| cation transport | GO:0006812 | 399 | 0.062 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.061 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.060 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.058 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.056 | |
| blood circulation | GO:0008015 | 195 | 0.053 | |
| glucosamine containing compound metabolic process | GO:1901071 | 3 | 0.052 | |
| membrane lipid catabolic process | GO:0046466 | 8 | 0.052 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.051 | |
| lipid transport | GO:0006869 | 98 | 0.051 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.050 | |
| positive regulation of necrotic cell death | GO:0010940 | 1 | 0.050 | |
| calcium ion transport | GO:0006816 | 159 | 0.049 | |
| organic anion transport | GO:0015711 | 137 | 0.049 | |
| endomembrane system organization | GO:0010256 | 147 | 0.048 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.048 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.048 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.047 | |
| positive regulation of actin nucleation | GO:0051127 | 3 | 0.046 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.045 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.043 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.043 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.042 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.042 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.042 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.041 | |
| necrotic cell death | GO:0070265 | 30 | 0.040 | |
| macroautophagy | GO:0016236 | 21 | 0.039 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.039 | |
| protein secretion | GO:0009306 | 111 | 0.038 | |
| regulation of ion transport | GO:0043269 | 215 | 0.038 | |
| dephosphorylation | GO:0016311 | 129 | 0.038 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.038 | |
| release of sequestered calcium ion into cytosol | GO:0051209 | 42 | 0.038 | |
| phospholipid transfer to membrane | GO:0006649 | 2 | 0.037 | |
| tissue homeostasis | GO:0001894 | 115 | 0.037 | |
| ceramide catabolic process | GO:0046514 | 7 | 0.037 | |
| muscle tissue development | GO:0060537 | 308 | 0.037 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.037 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.037 | |
| cellular response to thyroid hormone stimulus | GO:0097067 | 1 | 0.037 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.037 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.036 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.035 | |
| t cell activation | GO:0042110 | 289 | 0.035 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.035 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.035 | |
| diol metabolic process | GO:0034311 | 5 | 0.035 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.034 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.034 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.034 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.034 | |
| response to inorganic substance | GO:0010035 | 96 | 0.033 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.033 | |
| neuromuscular process | GO:0050905 | 99 | 0.033 | |
| water soluble vitamin metabolic process | GO:0006767 | 10 | 0.033 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.033 | |
| t cell homeostasis | GO:0043029 | 35 | 0.033 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.033 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.033 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.032 | |
| sensory perception of sound | GO:0007605 | 97 | 0.032 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.032 | |
| positive regulation of lipoprotein lipase activity | GO:0051006 | 3 | 0.032 | |
| regulation of vacuole organization | GO:0044088 | 4 | 0.032 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.031 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.031 | |
| skeletal system development | GO:0001501 | 356 | 0.031 | |
| renal system development | GO:0072001 | 225 | 0.031 | |
| germ cell development | GO:0007281 | 185 | 0.030 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.030 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.030 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.030 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.029 | |
| organic acid transport | GO:0015849 | 101 | 0.029 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.029 | |
| kidney development | GO:0001822 | 213 | 0.029 | |
| regulation of arp2 3 complex mediated actin nucleation | GO:0034315 | 1 | 0.029 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.028 | |
| zymogen activation | GO:0031638 | 41 | 0.028 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.028 | |
| uropod organization | GO:0032796 | 2 | 0.028 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.028 | |
| sensory perception of pain | GO:0019233 | 47 | 0.028 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.028 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.027 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.027 | |
| c21 steroid hormone biosynthetic process | GO:0006700 | 3 | 0.027 | |
| multicellular organismal macromolecule catabolic process | GO:0044266 | 1 | 0.027 | |
| lipid localization | GO:0010876 | 126 | 0.027 | |
| regulation of excitatory postsynaptic membrane potential | GO:0060079 | 41 | 0.027 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.027 | |
| ear development | GO:0043583 | 200 | 0.026 | |
| neuronal action potential | GO:0019228 | 54 | 0.026 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.026 | |
| sensory system development | GO:0048880 | 3 | 0.026 | |
| progesterone metabolic process | GO:0042448 | 4 | 0.025 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.025 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.025 | |
| vasodilation | GO:0042311 | 28 | 0.025 | |
| positive regulation of triglyceride lipase activity | GO:0061365 | 3 | 0.025 | |
| lipid storage | GO:0019915 | 36 | 0.025 | |
| bone development | GO:0060348 | 120 | 0.025 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.025 | |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.025 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.024 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.024 | |
| bone remodeling | GO:0046849 | 53 | 0.024 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process | GO:0006919 | 27 | 0.024 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.024 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.024 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.024 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.024 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.024 | |
| positive regulation of lamellipodium organization | GO:1902745 | 3 | 0.024 | |
| transmembrane transport | GO:0055085 | 412 | 0.024 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.024 | |
| l ascorbic acid metabolic process | GO:0019852 | 4 | 0.023 | |
| regulation of secretion | GO:0051046 | 274 | 0.023 | |
| visual behavior | GO:0007632 | 45 | 0.023 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.022 | |
| gland development | GO:0048732 | 330 | 0.022 | |
| hydrogen ion transmembrane transport | GO:1902600 | 25 | 0.022 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.022 | |
| vesicle organization | GO:0016050 | 60 | 0.022 | |
| regulation of dephosphorylation | GO:0035303 | 18 | 0.021 | |
| amino acid transport | GO:0006865 | 61 | 0.021 | |
| response to starvation | GO:0042594 | 65 | 0.021 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.021 | |
| glycosphingolipid metabolic process | GO:0006687 | 18 | 0.021 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.021 | |
| negative regulation of cellular catabolic process | GO:0031330 | 47 | 0.021 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.021 | |
| positive regulation of dephosphorylation | GO:0035306 | 6 | 0.021 | |
| natural killer cell degranulation | GO:0043320 | 3 | 0.020 | |
| interleukin 1 alpha secretion | GO:0050703 | 3 | 0.020 | |
| regulation of insulin secretion involved in cellular response to glucose stimulus | GO:0061178 | 31 | 0.020 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.020 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.020 | |
| neuron death | GO:0070997 | 154 | 0.020 | |
| golgi to endosome transport | GO:0006895 | 3 | 0.020 | |
| cellular response to glucose stimulus | GO:0071333 | 45 | 0.019 | |
| mesonephros development | GO:0001823 | 97 | 0.019 | |
| homeostasis of number of cells within a tissue | GO:0048873 | 25 | 0.019 | |
| n acetylglucosamine metabolic process | GO:0006044 | 3 | 0.019 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.019 | |
| peptide transport | GO:0015833 | 133 | 0.019 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.019 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.019 | |
| organelle localization | GO:0051640 | 179 | 0.019 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.019 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.018 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.018 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.018 | |
| membrane organization | GO:0061024 | 245 | 0.018 | |
| regulation of interleukin 1 alpha production | GO:0032650 | 4 | 0.018 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.018 | |
| regulation of transcription regulatory region dna binding | GO:2000677 | 9 | 0.018 | |
| inner ear receptor cell differentiation | GO:0060113 | 61 | 0.018 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.018 | |
| regulation of protein transport | GO:0051223 | 163 | 0.018 | |
| autophagic vacuole fusion | GO:0000046 | 1 | 0.018 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.018 | |
| regulation of cell activation | GO:0050865 | 289 | 0.018 | |
| arp2 3 complex mediated actin nucleation | GO:0034314 | 3 | 0.018 | |
| muscle contraction | GO:0006936 | 101 | 0.017 | |
| vesicle fusion | GO:0006906 | 16 | 0.017 | |
| endothelial cell chemotaxis | GO:0035767 | 3 | 0.017 | |
| regulation of neuron death | GO:1901214 | 134 | 0.017 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.017 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.017 | |
| multicellular organismal protein catabolic process | GO:0044254 | 1 | 0.017 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.016 | |
| positive regulation of interleukin 1 alpha production | GO:0032730 | 4 | 0.016 | |
| urogenital system development | GO:0001655 | 261 | 0.016 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.016 | |
| vesicle localization | GO:0051648 | 86 | 0.016 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.016 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.016 | |
| response to oxidative stress | GO:0006979 | 123 | 0.016 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.016 | |
| oligosaccharide catabolic process | GO:0009313 | 2 | 0.016 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.016 | |
| ossification | GO:0001503 | 216 | 0.016 | |
| anion transport | GO:0006820 | 177 | 0.016 | |
| phagolysosome assembly | GO:0001845 | 3 | 0.016 | |
| striated muscle cell development | GO:0055002 | 125 | 0.016 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.016 | |
| negative regulation of fatty acid oxidation | GO:0046322 | 5 | 0.016 | |
| circulatory system process | GO:0003013 | 197 | 0.016 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.015 | |
| lamellipodium morphogenesis | GO:0072673 | 5 | 0.015 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.015 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.015 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.015 | |
| regulation of cell shape | GO:0008360 | 39 | 0.015 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.015 | |
| defense response to other organism | GO:0098542 | 197 | 0.015 | |
| organelle fusion | GO:0048284 | 28 | 0.015 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.015 | |
| regulation of angiotensin metabolic process | GO:0060177 | 4 | 0.015 | |
| regulation of actin nucleation | GO:0051125 | 4 | 0.014 | |
| response to light stimulus | GO:0009416 | 135 | 0.014 | |
| nucleotide transmembrane transport | GO:1901679 | 2 | 0.014 | |
| maintenance of apical basal cell polarity | GO:0035090 | 3 | 0.014 | |
| positive regulation of macroautophagy | GO:0016239 | 3 | 0.014 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.014 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.014 | |
| negative regulation of cellular response to oxidative stress | GO:1900408 | 10 | 0.014 | |
| cell killing | GO:0001906 | 67 | 0.014 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.014 | |
| sensory perception | GO:0007600 | 245 | 0.014 | |
| regulation of vesicle fusion | GO:0031338 | 6 | 0.014 | |
| regulation of binding | GO:0051098 | 111 | 0.014 | |
| multicellular organismal protein metabolic process | GO:0044268 | 2 | 0.014 | |
| cellular response to starvation | GO:0009267 | 57 | 0.014 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.014 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.014 | |
| positive regulation of sequestering of triglyceride | GO:0010890 | 4 | 0.014 | |
| cell chemotaxis | GO:0060326 | 81 | 0.014 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.014 | |
| intracellular lipid transport | GO:0032365 | 3 | 0.013 | |
| chemotaxis | GO:0006935 | 247 | 0.013 | |
| regulation of lamellipodium morphogenesis | GO:2000392 | 1 | 0.013 | |
| negative regulation of osteoblast proliferation | GO:0033689 | 4 | 0.013 | |
| peptide secretion | GO:0002790 | 114 | 0.013 | |
| positive regulation of interleukin 1 secretion | GO:0050716 | 14 | 0.013 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.013 | |
| organelle membrane fusion | GO:0090174 | 1 | 0.013 | |
| protein targeting | GO:0006605 | 143 | 0.013 | |
| adult behavior | GO:0030534 | 135 | 0.013 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.013 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.013 | |
| synaptic vesicle localization | GO:0097479 | 59 | 0.013 | |
| learning or memory | GO:0007611 | 148 | 0.013 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.013 | |
| interleukin 6 production | GO:0032635 | 58 | 0.013 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.013 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.013 | |
| wound healing | GO:0042060 | 157 | 0.013 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.013 | |
| myosin filament organization | GO:0031033 | 3 | 0.013 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.013 | |
| nuclear import | GO:0051170 | 95 | 0.013 | |
| cellular response to gonadotropin stimulus | GO:0071371 | 4 | 0.013 | |
| lateral inhibition | GO:0046331 | 1 | 0.013 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.013 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.012 | |
| regulation of glutamate secretion | GO:0014048 | 3 | 0.012 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class i | GO:0019885 | 3 | 0.012 | |
| positive regulation of calcium ion transport | GO:0051928 | 27 | 0.012 | |
| antigen processing and presentation of peptide antigen | GO:0048002 | 29 | 0.012 | |
| water soluble vitamin biosynthetic process | GO:0042364 | 3 | 0.012 | |
| bone resorption | GO:0045453 | 38 | 0.012 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.012 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.012 | |
| regulation of interleukin 1 alpha secretion | GO:0050705 | 3 | 0.012 | |
| antigen processing and presentation of exogenous antigen | GO:0019884 | 26 | 0.012 | |
| bone mineralization | GO:0030282 | 54 | 0.012 | |
| synapse organization | GO:0050808 | 125 | 0.012 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.012 | |
| lung morphogenesis | GO:0060425 | 50 | 0.012 | |
| embryonic olfactory bulb interneuron precursor migration | GO:0021831 | 2 | 0.012 | |
| nuclear division | GO:0000280 | 158 | 0.012 | |
| hair cell differentiation | GO:0035315 | 40 | 0.012 | |
| hormone secretion | GO:0046879 | 128 | 0.012 | |
| synaptic vesicle transport | GO:0048489 | 57 | 0.012 | |
| positive regulation of mitochondrial calcium ion concentration | GO:0051561 | 3 | 0.012 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.012 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.012 | |
| proton transport | GO:0015992 | 35 | 0.012 | |
| positive regulation of neutrophil apoptotic process | GO:0033031 | 1 | 0.012 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.012 | |
| learning | GO:0007612 | 98 | 0.012 | |
| hydrogen transport | GO:0006818 | 35 | 0.012 | |
| progesterone biosynthetic process | GO:0006701 | 1 | 0.012 | |
| response to calcium ion | GO:0051592 | 20 | 0.011 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.011 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.011 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.011 | |
| organelle fission | GO:0048285 | 170 | 0.011 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.011 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.011 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.011 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.011 | |
| amine metabolic process | GO:0009308 | 45 | 0.011 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.011 | |
| establishment of synaptic vesicle localization | GO:0097480 | 57 | 0.011 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.011 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.011 | |
| antigen processing and presentation | GO:0019882 | 47 | 0.011 | |
| canonical wnt signaling pathway involved in negative regulation of apoptotic process | GO:0044336 | 4 | 0.011 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.011 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.011 | |
| mapk cascade | GO:0000165 | 281 | 0.011 | |
| intracellular protein transport | GO:0006886 | 204 | 0.011 | |
| chloride transmembrane transport | GO:1902476 | 24 | 0.011 | |
| lipid catabolic process | GO:0016042 | 69 | 0.011 | |
| microglia development | GO:0014005 | 2 | 0.011 | |
| response to metal ion | GO:0010038 | 47 | 0.011 | |
| cytochrome complex assembly | GO:0017004 | 3 | 0.011 | |
| negative regulation of interleukin 6 production | GO:0032715 | 17 | 0.011 | |
| skin development | GO:0043588 | 220 | 0.011 | |
| regulation of triglyceride biosynthetic process | GO:0010866 | 10 | 0.011 | |
| regulation of protein import into nucleus | GO:0042306 | 52 | 0.010 | |
| hormone metabolic process | GO:0042445 | 86 | 0.010 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.010 | |
| dicarboxylic acid transport | GO:0006835 | 29 | 0.010 | |
| regulation of postsynaptic membrane potential | GO:0060078 | 48 | 0.010 | |
| peptide hormone processing | GO:0016486 | 9 | 0.010 | |
| tissue remodeling | GO:0048771 | 102 | 0.010 | |
| pigmentation | GO:0043473 | 71 | 0.010 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.010 | |
| regulation of system process | GO:0044057 | 200 | 0.010 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.010 | |
| vagus nerve morphogenesis | GO:0021644 | 2 | 0.010 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.010 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.010 | |
| chromatin organization | GO:0006325 | 206 | 0.010 | |
| establishment of melanosome localization | GO:0032401 | 11 | 0.010 | |
| activation of cysteine type endopeptidase activity | GO:0097202 | 27 | 0.010 | |
| insulin secretion | GO:0030073 | 89 | 0.010 | |
| positive regulation of peptide secretion | GO:0002793 | 33 | 0.010 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.010 | |
